Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis P Garrison

Showing results (141-150 of 190) with videos related to

Pageof 19
Sort By:
BMJ Open|May 4, 2023
Assessing the potential cost-effectiveness of centralised versus point-of-care testing for hepatitis C virus in Pakistan: a model-based comparisonJoseph B Babigumira, James K Karichu, Samantha Clark, et al.
Journal of Comparative Effectiveness Research|July 19, 2024
Val (EU) xit: do we need an international ISPOR value flower?Sreeram V Ramagopalan, Manuel Gomes, Isabelle Durand-Zaleski, et al.
Cost Effectiveness and Resource Allocation : C/E|July 21, 2017
Cost-effectiveness of cervical cancer screening and preventative cryotherapy at an HIV treatment clinic in KenyaMarita R Zimmermann, Elisabeth Vodicka, Joseph B Babigumira, et al.
Journal of Managed Care & Specialty Pharmacy|March 23, 2016
Using Certification to Promote Uptake of Real-World Evidence by PayersJodi B Segal, Joel D Kallich, Emma R Oppenheim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Association between health-related quality of life and body mass after adjustable gastric banding: a nonlinear approachVincent W Lin, Edwin S Wong, Andrew Wright, et al.
Pharmacoepidemiology and Drug Safety|May 3, 2016
Sentinel site active surveillance of safety of first-line antiretroviral medicines in NamibiaMarita Mann, Assegid Mengistu, Johannes Gaeseb, et al.
International Journal of Technology Assessment in Health Care|December 12, 2024
Food for thought: more explicit guidance for inclusion of caregiver perspectives in health technology assessmentSiobhan Bourke, Chris Skedgel, Yasmina Martí-Gil, et al.
Journal of Personalized Medicine|November 10, 2016
Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to ValueYixi Chen, Gregory F Guzauskas, Chengming Gu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 29, 2021
Hemophilia Gene Therapy Value Assessment: Methodological Challenges and RecommendationsLouis P Garrison, Ed Pezalla, Adrian Towse, et al.
Journal of Medical Economics|November 26, 2014
Lifetime cost of everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the USAllison Perrin, Steven Sherman, Sumanta Pal, et al.
Pageof 19

Showing results (141-150 of 190) with videos related to

Sort By:
Pageof 19
BMJ Open|May 4, 2023
Assessing the potential cost-effectiveness of centralised versus point-of-care testing for hepatitis C virus in Pakistan: a model-based comparisonJoseph B Babigumira, James K Karichu, Samantha Clark, et al.
Journal of Comparative Effectiveness Research|July 19, 2024
Val (EU) xit: do we need an international ISPOR value flower?Sreeram V Ramagopalan, Manuel Gomes, Isabelle Durand-Zaleski, et al.
Cost Effectiveness and Resource Allocation : C/E|July 21, 2017
Cost-effectiveness of cervical cancer screening and preventative cryotherapy at an HIV treatment clinic in KenyaMarita R Zimmermann, Elisabeth Vodicka, Joseph B Babigumira, et al.
Journal of Managed Care & Specialty Pharmacy|March 23, 2016
Using Certification to Promote Uptake of Real-World Evidence by PayersJodi B Segal, Joel D Kallich, Emma R Oppenheim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Association between health-related quality of life and body mass after adjustable gastric banding: a nonlinear approachVincent W Lin, Edwin S Wong, Andrew Wright, et al.
Pharmacoepidemiology and Drug Safety|May 3, 2016
Sentinel site active surveillance of safety of first-line antiretroviral medicines in NamibiaMarita Mann, Assegid Mengistu, Johannes Gaeseb, et al.
International Journal of Technology Assessment in Health Care|December 12, 2024
Food for thought: more explicit guidance for inclusion of caregiver perspectives in health technology assessmentSiobhan Bourke, Chris Skedgel, Yasmina Martí-Gil, et al.
Journal of Personalized Medicine|November 10, 2016
Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to ValueYixi Chen, Gregory F Guzauskas, Chengming Gu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 29, 2021
Hemophilia Gene Therapy Value Assessment: Methodological Challenges and RecommendationsLouis P Garrison, Ed Pezalla, Adrian Towse, et al.
Journal of Medical Economics|November 26, 2014
Lifetime cost of everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the USAllison Perrin, Steven Sherman, Sumanta Pal, et al.
Pageof 19